Medical Advocates
Toxoplasmosis
  Drugs
             
Atovaquone
Cotrimoxazole
Itraconazole
Dexamathasone
Pyrimethamine
Sulfadiazine





 
Toxoplasmosis Main Page Main New/Noteworthy Home Page   
Last Update:  September 23, 2008
 Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader
Atovaquone
       

    Journal Papers, Abstracts, and Commentaries

  Randomized phase II trial of atovaquone with pyrimethamine or sulfadiazine for
treatment of toxoplasmic encephalitis in patients with acquired immunodeficiency
syndrome: ACTG 237/ANRS 039 Study. AIDS Clinical Trials Group 237/Agence
Nationale de Recherche sur le SIDA, Essai 039.
Chirgwin K, Hafner R, Leport  et al  
Clin Infect Dis 2002 May 1;34(9):1243-50
 Abstract
Cotrimoxazole
       

    Journal Papers, Abstracts, and Commentaries

  Primary prevention with cotrimoxazole for HIV-1-infected adults: results of the pilot
 study in Dakar,
Senegal.Maynart M, Lievre L, Sow PS, et al.
J Acquir Immune Defic Syndr 2001 Feb 1;26(2):130-6
 Abstract
Dexamathasone
       

    Journal Papers, Abstracts, and Commentaries

  Cytokine and antibody responses of reactivated murine toxoplasmosis upon administration
of dexamathasone.
Kang KN, Choi IU, Shin DW, Lee YH.
Korean J Parasitol. 2006 Sep;44(3):209-19
 Abstract
Itraconazole
       

    Journal Papers, Abstracts, and Commentaries

  Itraconazole affects Toxoplasma gondii endodyogeny.
Martins-Duarte Edos S, de Souza W, Vommaro RC.
FEMS Microbiol Lett. 2008 May;282(2):290-8.
Abstract
Pyrimethamine
       

    Journal Papers, Abstracts, and Commentaries

  Drug monitoring of pyrimethamine during maintenance therapy of toxoplasmic
encephalitis in patients with advanced HIV infection during HAART.
Langmann P, Schirmer D, Zilly M, Klinker H. 
Med Sci Monit. 2004 May;10(5):PI65-9.
 Abstract
Sulfadiazine
       

    Journal Papers, Abstracts, and Commentaries

  Primary prevention with cotrimoxazole for HIV-1-infected adults: results of
the pilot study in Dakar,
Senegal.Maynart M, Lievre L, Sow PS, et al.
J Acquir Immune Defic Syndr 2001 Feb 1;26(2):130-6
 Abstract
 

Toxoplasmosis Main Page Main New/Noteworthy Home Page   

Toxoplasmosis Drugs